Evidence map›Paper›PMID 27164082›Full record

ArticleInternational journal of molecular sciences2016

Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling.

Shinya Takigawa, Andy Chen, Akinobu Nishimura, Shengzhi Liu, Bai-Yan Li, Akihiro Sudo, Hiroki Yokota, Kazunori Hamamura

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. ISR Modulators in Neurological Diseases.Current neuropharmacology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Shinya TakigawaDepartment of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA. wonderfulmexicancombo@hotmail.com.
Andy ChenWeldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 40907, USA. andychen@iupui.edu.
Akinobu NishimuraDepartment of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA. meiten0903@gmail.com.
Shengzhi LiuDepartment of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA. liu441@iupui.edu.
Bai-Yan LiDepartment of Pharmacology, School of Pharmacy, Harbin Medical University, Harbin 150081, China. liby@ems.hrbmu.edu.cn.
Akihiro SudoDepartment of Orthopadic Surgery, Mie University Graduate School of Medicine, Mie 514-8507, Japan. a-sudou@clin.medic.mie-u.ac.jp.
Hiroki YokotaDepartment of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA. hyokota@iupui.edu.
Kazunori HamamuraDepartment of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA. hamak@dpc.agu.ac.jp.
University of Indianapolis · USHarbin Medical University · CNMie University · JPPurdue University West Lafayette · US

Funding

Boston University Clinical and Translational Science Institute - U ProgramU54TR001012 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2014 to 2014
$3.9M
NCATS NIH HHS U54 TR001012
6 · The paper itself

Abstract

Integrated stress responses (ISR) may lead to cell death and tissue degeneration via eukaryotic translation initiation factor 2 α (eIF2α)-mediated signaling. Alleviating ISR by modulating eIF2α phosphorylation can reduce the symptoms associated with various diseases. Guanabenz is known to elevate the phosphorylation level of eIF2α and reduce pro-inflammatory responses. However, the mechanism of its action is not well understood. In this study, we investigated the signaling pathway through which guanabenz induces anti-inflammatory effects in immune cells, in particular macrophages. Genome-wide mRNA profiling followed by principal component analysis predicted that colony stimulating factor 2 (Csf2, or GM-CSF as granulocyte macrophage colony stimulating factor) is involved in the responses to guanabenz. A partial silencing of Csf2 or eIF2α by RNA interference revealed that Interleukin-6 (IL6), Csf2, and Cyclooxygenase-2 (Cox2) are downregulated by guanabenz-driven phosphorylation of eIF2α. Although expression of IL1β and Tumor Necrosis Factor-α (TNFα) was suppressed by guanabenz, their downregulation was not directly mediated by eIF2α signaling. Collectively, the result herein indicates that anti-inflammatory effects by guanabenz are mediated by not only eIF2α-dependent but also eIF2α-independent signaling.

Indexed as

Down-RegulationSignal TransductionAnimalsAnti-Inflammatory AgentsBone Marrow CellsCells, CulturedCyclooxygenase 2Eukaryotic Initiation Factor-2Granulocyte-Macrophage Colony-Stimulating FactorGuanabenzHumansInflammationInterleukin-6Jurkat CellsMacrophagesMast CellsAnti-Inflammatory AgentsCyclooxygenase 2Eukaryotic Initiation Factor-2Granulocyte-Macrophage Colony-Stimulating FactorGuanabenzInterleukin-6Tumor Necrosis Factor-alphaCsf2 (GM-CSF)eIF2α signalingguanabenzinflammationmicroarray

Identifiers

PMID27164082
PMCPMC4881500
OpenAlexW2345765297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.